Answers are grounded in this paper and cite their sources.
Letters5 October 1999CD123 hiDendritic Cell Lymphoma: An Unusual Case of Non-Hodgkin LymphomaPaulo Lúcio, MD, Antonio Parreira, and Alberto OrfaoPaulo Lúcio, MDPortuguese Institute of Oncology; Lisbon, Portugal (Lúcio)Portuguese Institute of Oncology; Lisbon, Portugal (Parreira)University of Salamanca; Salamanca, Spain (Orfao), Antonio ParreiraPortuguese Institute of Oncology; Lisbon, Portugal (Lúcio)Portuguese Institute of Oncology; Lisbon, Portugal (Parreira)University of Salamanca; Salamanca, Spain (Orfao), and Alberto OrfaoPortuguese Institute of Oncology; Lisbon, Portugal (Lúcio)Portuguese Institute of Oncology; Lisbon, Portugal (Parreira)University of Salamanca; Salamanca, Spain (Orfao)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-131-7-199910050-00035 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:A new hemopoietic-derived lineage of dendritic cells was recently reported; this lineage is characterized by a particularly high expression of the interleukin-3 receptor α-chain (CD123 hi) (1). Unlike Langerhans cells, normal CD123 hi dendridic cells migrate through peripheral blood to lymphoid tissues in the absence of inflammatory stimuli; they are found in fetal and adult lymph nodes, tonsils, and thymus. No tumoral counterpart of this dendritic cell subset has yet been identified.We describe a patient with a histopathologic diagnosis of non-Hodgkin lymphoma in whom immunophenotypic and molecular studies ruled out the B, T, or natural killer ...References1. Olweus J, BitMansour A, Warnke R, Thompson P, Carballido J, Picker L, et al . Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci U S A. 1997;94:12551-6. CrossrefMedlineGoogle Scholar2. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al . A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-92. CrossrefMedlineGoogle Scholar3. Cabanillas F, Hagemeister FB, Bodey GP, Freireich EJ. IMVP16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy. Blood. 1982;60:693-7. CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Paulo Lúcio, MD; Antonio Parreira; Alberto OrfaoAffiliations: Portuguese Institute of Oncology; Lisbon, Portugal (Lúcio)Portuguese Institute of Oncology; Lisbon, Portugal (Parreira)University of Salamanca; Salamanca, Spain (Orfao) PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoOn the Death of House Officers Faith Fitzgerald and T. Jock Murray Metrics Cited byReferencesTranscriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesisTagraxofusp and anti-CD123 in blastic plasmacytoid dendritic cell neoplasm: a new hopeMolecular Features of Blastic Plasmacytoid Dendritic Cell NeoplasmBlastic Plasmacytoid Dendritic Cell Neoplasm–Current InsightsCD123 as a Therapeutic Target in the Treatment of Hematological MalignanciesMulticenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmarkBlastic Plasmacytoid Dendritic Cell NeoplasmClinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in KoreaNeoplasms derived from plasmacytoid dendritic cellsClassification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profileBruise-like cutaneous lesions as the early presentation of blastic plasmacytoid dendritic cell neoplasmBlastic plasmacytoid dendritic cell neoplasia - a rare type of acute leukemiaBlastic plasmacytoid dendritic cell neoplasm: a report of four cases and review of the literatureClinicopathological features and prognostic significance of CXCL12 in blastic plasmacytoid dendritic cell neoplasmLeukemic Manifestation of Blastic Plasmacytoid Dendritic Cell Neoplasm Lacking Skin Lesion : A Borderline Case between Acute Monocytic LeukemiaBlastic Plasmacytoid Dendritic Cell NeoplasmExtended diagnostic criteria for plasmacytoid dendritic cell leukaemiaPlasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?Vaccine strategies to treat lymphoproliferative disordersCD4(+) CD56(+) Lineage-Negative Malignancies Are Rare Tumors of Plasmacytoid Dendritic CellsExtensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells 5 October 1999Volume 131, Issue 7Page: 549-550KeywordsBlood cellsDendritic cellsDiffuse large B-cell lymphomaLymphocytesLymphomaPulmonary diseasesResearch laboratoriesT cell receptorsThymusTonsils ePublished: 15 August 2000 Issue Published: 5 October 1999 Copyright & PermissionsCopyright © 1999 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Lúcio et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: